Daohong Zhou

Seminars

Tuesday 28th October 2025
Pre-Clinical & Clinical Development of DT-2216, A Selective & Potent BCL-XL Degrader for Cancer Therapy
2:30 pm

Download the Full Event Guide for Full Session Details.